| 000 | 01757 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513183421.0 | ||
| 264 | 0 | _c19990603 | |
| 008 | 199906s 0 0 eng d | ||
| 022 | _a0003-4967 | ||
| 024 | 7 |
_a10.1136/ard.58.2.79 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHaagsma, C J | |
| 245 | 0 | 0 |
_aInfluence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _cFeb 1999 |
||
| 300 |
_a79-84 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xblood |
| 650 | 0 | 4 |
_aDigestive System _xdrug effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFolic Acid _xblood |
| 650 | 0 | 4 |
_aHomocysteine _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadverse effects |
| 650 | 0 | 4 | _aMethylenetetrahydrofolate Reductase (NADPH2) |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aOxidoreductases Acting on CH-NH Group Donors _xgenetics |
| 650 | 0 | 4 |
_aSulfasalazine _xadverse effects |
| 650 | 0 | 4 |
_aVitamin B 12 _xblood |
| 700 | 1 | _aBlom, H J | |
| 700 | 1 | _avan Riel, P L | |
| 700 | 1 | _avan't Hof, M A | |
| 700 | 1 | _aGiesendorf, B A | |
| 700 | 1 | _avan Oppenraaij-Emmerzaal, D | |
| 700 | 1 | _avan de Putte, L B | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 58 _gno. 2 _gp. 79-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.58.2.79 _zAvailable from publisher's website |
| 999 |
_c10302203 _d10302203 |
||